An intravenous monoclonal antibody (passive immunotherapy) for the treatment of patients with mild early-stage Alzheimer’s disease.
If you have a Hayes login, click here to view the full report on the Knowledge Center.
An intravenous monoclonal antibody (passive immunotherapy) for the treatment of patients with mild early-stage Alzheimer’s disease.
If you have a Hayes login, click here to view the full report on the Knowledge Center.